Merck
CN
Search Within

125-02-0

应用筛选条件
关键词:'125-02-0'
显示 1-2 共 2 条结果 关于 "125-02-0" 范围 论文
Jonathon Torchia et al.
The Lancet. Oncology, 16(5), 569-582 (2015-04-18)
Rhabdoid brain tumours, also called atypical teratoid rhabdoid tumours, are lethal childhood cancers with characteristic genetic alterations of SMARCB1/hSNF5. Lack of biological understanding of the substantial clinical heterogeneity of these tumours restricts therapeutic advances. We integrated genomic and clinicopathological analyses
John R Teerlink et al.
Lancet (London, England), 381(9860), 29-39 (2012-11-13)
Serelaxin, recombinant human relaxin-2, is a vasoactive peptide hormone with many biological and haemodynamic effects. In a pilot study, serelaxin was safe and well tolerated with positive clinical outcome signals in patients with acute heart failure. The RELAX-AHF trial tested
1/1